150 related articles for article (PubMed ID: 11753902)
21. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
22. Toward immunomodulatory and anti-inflammatory properties of statins.
Arnaud C; Braunersreuther V; Mach F
Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases.
Chow SC
Arch Immunol Ther Exp (Warsz); 2009; 57(4):243-51. PubMed ID: 19578811
[TBL] [Abstract][Full Text] [Related]
24. Potential antitumor effects of statins (Review).
Jakobisiak M; Golab J
Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
[TBL] [Abstract][Full Text] [Related]
25. [The pleiotropic effects of statins].
Wolfovitz E
Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
[TBL] [Abstract][Full Text] [Related]
26. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
27. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
28. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
Moonis M; Fisher M
Expert Rev Neurother; 2004 Mar; 4(2):241-7. PubMed ID: 15853565
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease.
Undas A; Brozek J; Musial J
Clin Lab; 2002; 48(5-6):287-96. PubMed ID: 12071579
[TBL] [Abstract][Full Text] [Related]
30. HMG-CoA reductase inhibitors in organ transplantation.
Motomura N; Saito S; Foegh ML
J Nephrol; 1997; 10(2):68-76. PubMed ID: 9238613
[TBL] [Abstract][Full Text] [Related]
31. [Transplant coronary artery disease--treatment with statins].
Wolszakiewicz J; Bilińska M
Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
[TBL] [Abstract][Full Text] [Related]
32. Impact and management of hyperlipidemia posttransplantation.
Fellström B
Transplantation; 2000 Dec; 70(11 Suppl):SS51-7. PubMed ID: 11152232
[TBL] [Abstract][Full Text] [Related]
33. Statins as novel immunomodulators: from cell to potential clinical benefit.
Mach F
Thromb Haemost; 2003 Oct; 90(4):607-10. PubMed ID: 14515180
[TBL] [Abstract][Full Text] [Related]
34. Statins in heart transplantation.
Kittleson MM; Kobashigawa JA
Clin Transpl; 2013; ():135-43. PubMed ID: 25095502
[TBL] [Abstract][Full Text] [Related]
35. Statins in solid organ transplantation: is there an immunosuppressive effect?
Kobashigawa JA
Am J Transplant; 2004 Jul; 4(7):1013-8. PubMed ID: 15196056
[TBL] [Abstract][Full Text] [Related]
36. Statins as immunosuppressive agents.
Kobashigawa JA
Liver Transpl; 2001 Jun; 7(6):559-61. PubMed ID: 11443589
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the inflammatory process by statins.
Crisby M
Drugs Today (Barc); 2003 Feb; 39(2):137-43. PubMed ID: 12698208
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive effects of statins.
Mach F
Atheroscler Suppl; 2002 May; 3(1):17-20. PubMed ID: 12044581
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients.
Sun HY; Singh N
Clin Infect Dis; 2009 Mar; 48(6):745-55. PubMed ID: 19193110
[TBL] [Abstract][Full Text] [Related]
40. Chronic kidney disease as a cardiovascular risk state and considerations for the use of statins.
McCullough PA; Rocher LR; Nistala R; Whaley-Connell A
J Clin Lipidol; 2008 Oct; 2(5):318-27. PubMed ID: 21291756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
